Hereditary hyperuricemia and renal disease

Area of Science:

• Nephrology
• Genetics
• Metabolic Disorders

Background:

• Hyperuricemia and gout exhibit familial clustering, suggesting a genetic basis.
• Two rare single-gene disorders, hypoxanthine-guaninephosphoribosyl transferase (HPRT) deficiency and PPriboseP synthase overactivity, cause urate overproduction and kidney damage.
• Familial juvenile hyperuricemic nephropathy (FJHN) and autosomal-dominant medullary cystic kidney disease (ADMCKD) are characterized by decreased urate excretion and normal urate production.

Purpose of the Study:

• To explore the genetic underpinnings of hyperuricemia and gout.
• To investigate the genetic heterogeneity of FJHN and ADMCKD.
• To determine if genes implicated in FJHN and ADMCKD contribute to polygenic hyperuricemia in gout.

Main Methods:

• Review of genetic disorders associated with hyperuricemia and kidney disease.
• Analysis of mutations in the uromodulin gene in FJHN and ADMCKD.
• Comparison of genetic factors in rare hyperuricemic nephropathies and common gout.

Main Results:

• Mutations in the uromodulin gene are associated with approximately one-third of FJHN and ADMCKD cases.
• Genetic heterogeneity exists within these hyperuricemic nephropathies.
• The contribution of genes involved in FJHN and ADMCKD to polygenic hyperuricemia in gout is currently unexplored.

Conclusions:

• While specific gene mutations cause rare forms of hyperuricemia and kidney disease, their role in common gout requires further investigation.
• Understanding the genetic basis of urate metabolism disorders is crucial for managing kidney disease and gout.
• Further research is needed to elucidate the genetic links between rare hyperuricemic nephropathies and the polygenic nature of gout.